News

RNA vaccines train the immune system in a similar way to traditional vaccines, but they use a different strategy to get there ...
As we previously discussed, beginning in 2022, a series of patent infringement lawsuits were filed against Moderna and ...
Researchers from Agency for Science, Technology and Research in Singapore recently published a review article exploring how ...
Concern is growing among public health experts that anti-vaccine sentiment within federal and state governments may derail emerging and cutting-edge vaccines that are now awaiting regulatory approval ...
Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.
Heidelberg biochemists and structural biologists from Shanghai unravel the roles of two key regulatory factors in mRNA ...
Wacker Biotech announced a strategic collaboration with RNAV8 Bio, a pioneer in mRNA engineering for the development of ...
Messenger RNA (mRNA) is the genetic blueprint that tells cells how to produce ... Additionally, the research highlighted the ...
A team of researchers led by Dr. Kim V. Narry, director of the Center for RNA Research at the Institute for Basic Science (IBS), has uncovered a key cellular mechanism that affects the function of ...
Drug developers will now have enhanced abilities to rapidly prototype, test, iterate, and scale up their mRNA therapeutics.
Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...
A team of researchers led by Dr. Kim V. Narry, director of the Center for RNA Research at the Institute for Basic Science ...